Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation
Jinju Oh, Hyun Joo Lee, Tae Sung Lee, Ju Hyun Kim, Suk Bong Koh, Youn Seok Choi
Obstet Gynecol Sci. 2016;59(4):269-278.   Published online 2016 Jul 13     DOI: https://doi.org/10.5468/ogs.2016.59.4.269
Citations to this article as recorded by Crossref logo
Lung cancer risk in workers occupationally exposed to polycyclic aromatic hydrocarbons with emphasis on the role of DNA repair gene
Gehan Moubarz, Amal Saad-Hussein, Eman M. Shahy, Heba Mahdy-Abdallah, Atef M. F. Mohammed, Inas A. Saleh, Mona A. M. Abo-Zeid, Mahmoud T. Abo-Elfadl
International Archives of Occupational and Environmental Health.2023; 96(2): 313.     CrossRef
Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making
Liu Shi, Yuxin Liu, Junyun Li, Jia Kou, Yi Ouyang, Foping Chen, Xiaodan Huang, Lanqing Huo, Lin Huang, Xinping Cao
Journal of Cancer Research and Clinical Oncology.2023; 149(9): 5999.     CrossRef
Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma
Lin Qin
Journal of Cancer Research and Clinical Oncology.2023; 149(11): 9167.     CrossRef
Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
Peng Chen, Liang Jiao, Fang Ren, Dan-Bo Wang
BMC Cancer.2020;[Epub]     CrossRef
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Jingxuan Fu, Weiping Wang, Yidan Wang, Chengeng Liu, Peichang Wang
Radiation Oncology.2019;[Epub]     CrossRef
Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy
Yue-Feng Wen, Tian-Tian Cheng, Xiao-Long Chen, Wen-Jin Huang, Hai-Hua Peng, Tong-Chong Zhou, Xiao-Dan Lin, Li-Si Zeng, Masaru Katoh
PLOS ONE.2018; 13(10): e0204334.     CrossRef
Hormone producing gynecological tumors: pathologic entities and clinical significance
Agedi N. Boto, Pei Hui
Expert Review of Endocrinology & Metabolism.2018; 13(1): 9.     CrossRef
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
Wei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua Yao
Journal of Gynecologic Oncology.2017;[Epub]     CrossRef
The comparison of Architect SCC and cobas SCC tests
Ewa Wójcik, Krzysztof Reinfuss, Zofia Stasik, Urszula Rychlik, Jadwiga Tarapacz, Jan K. Kulpa
Diagnostyka Laboratoryjna.2017; 53(3): 147.     CrossRef